NYSE$EXK
Endeavour Silver Corp · Q3 2025 earnings
Q3 2025 earnings · · Investor relations
Briefing
EXK reported Q3 2025, revenue of $142.8M, a net loss of $33M.
For Q3 2025, EXK reported revenue of $142.8M, a net loss of $33M. Management discusses operating trends, liquidity, and strategic priorities as disclosed in the quarterly filing.
- Revenue $142.8M.
- Net loss $33M.
- EXK updated clinical, capital, or portfolio priorities in the filing.
Headline financials
Revenue & EPS history
Endeavour Silver · Revenue · Quarterly
$143M
Forward guidance
Management discusses EXK's outlook, capital deployment, and key risks as disclosed in the earnings materials and periodic report.
Tailwinds
- EXK cited progress on strategic priorities in the quarterly filing.
- Liquidity and balance sheet support continued operations and investment.
Headwinds
- GAAP profitability remained under pressure in the reported quarter.
- Macro, competitive, and regulatory factors may affect near-term results.
- R&D, credit, or project timing can create quarter-to-quarter volatility.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
-0.7%
Avg return
Earnings day
-4.2%
Avg return
5 days after
-0.2%
Avg return
30 days after
40%
19 / 47 earnings
Positive
+26.8%
Q3 2020
Best reaction
-25.5%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | -1.4% | +11.5% | +18.4% | |
| Q2 2025 | -4.5% | -3.1% | +6.6% | |
| Q4 2024 | +24.2% | -3.0% | +43.3% | |
| Q1 2025 | -0.6% | -3.0% | +43.3% | |
| Q2 2024 | -25.5% | -29.9% | -32.2% | |
| Q4 2023 | +13.2% | +18.0% | +53.4% | |
| Q3 2023 | -10.2% | -10.6% | -8.8% | |
| Q2 2023 | -3.8% | -4.5% | -17.6% | |
| Q1 2023 | -17.9% | -19.5% | -25.2% | |
| Q3 2022 | -5.5% | -2.8% | -6.9% | |
| Q2 2022 | -4.5% | -6.1% | -20.7% | |
| Q1 2022 | +1.3% | +13.9% | +28.1% | |
| Q4 2021 | +9.0% | +5.1% | -3.9% | |
| Q3 2021 | +3.8% | +9.4% | -21.8% | |
| Q2 2021 | +5.6% | +0.7% | +3.8% | |
| Q1 2021 | -3.3% | -0.5% | +24.6% | |
| Q4 2020 | +6.4% | -7.6% | -15.9% | |
| Q3 2020 | +26.8% | +11.0% | +8.8% | |
| Q2 2020 | +1.2% | -4.4% | -5.6% | |
| Q1 2020 | -5.6% | -3.5% | +41.0% | |
| Q4 2019 | -9.4% | -23.2% | -24.1% | |
| Q3 2019 | -8.8% | -12.7% | -9.6% | |
| Q2 2019 | -1.5% | -6.8% | +1.5% | |
| Q1 2019 | -2.3% | -12.7% | -12.2% | |
| Q4 2018 | +8.0% | -2.8% | +7.6% | |
| Q3 2018 | +3.4% | +3.9% | -10.2% | |
| Q2 2018 | -10.1% | -12.2% | -22.0% | |
| Q1 2018 | -5.9% | -6.6% | -7.6% | |
| Q4 2017 | -1.8% | +4.4% | +5.3% | |
| Q3 2017 | +4.5% | +8.6% | +8.1% | |
| Q2 2017 | -20.8% | -23.5% | -14.2% | |
| Q4 2016 | -24.6% | -31.7% | -27.6% | |
| Q3 2016 | +7.3% | +0.0% | -13.3% | |
| Q2 2016 | +2.5% | +2.7% | -2.9% | |
| Q1 2016 | +10.2% | — | — | |
| Q4 2015 | +20.7% | — | — | |
| Q3 2015 | -5.5% | — | — | |
| Q2 2015 | +9.6% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | -8.8% | — | — | |
| Q2 2014 | -4.1% | — | — | |
| Q2 2013 | -7.5% | — | — | |
| Q2 2011 | -6.9% | — | — | |
| Q1 2011 | +2.2% | — | — | |
| Q3 2010 | -0.8% | — | — | |
| Q2 2010 | +10.2% | — | — | |
| Q1 2010 | -3.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro